Breaking News Instant updates and real-time market news.

MU

Micron

$34.12

0.23 (0.68%)

05:27
12/19/18
12/19
05:27
12/19/18
05:27

Micron downgraded to Sector Perform from Outperform at RBC Capital

RBC Capital analyst Amit Daryanani downgraded Micron Technology to Sector Perform and lowered his price target for the shares to $40 from $59.

  • 08

    Jan

MU Micron
$34.12

0.23 (0.68%)

12/17/18
COWN
12/17/18
NO CHANGE
Target $45
COWN
Outperform
Micron price target lowered to $45 from $62 at Cowen
Cowen analyst Karl Ackerman lowered his price target on Micron to $45 from $62 and reduced his CY19 estimate to $7.00 from $8.25, which he notes is below the Street's $9.25. He believes the buyside may have already priced in even lower earnings for 2019. He said the near-term remains challenged and expects the company to significantly guide below consensus after they pre-announced an in-line quarter just a month ago. However, Ackerman maintained his Outperform rating on Micron shares.
12/13/18
MKMP
12/13/18
NO CHANGE
Target $50
MKMP
Buy
Micron FY19 EPS lowered at MKM Partners on slowing 'bit growth'
MKM Partners analyst Ruben Roy kept his Buy rating and $50 price target on Micron but lowered his FY19 EPS view to $10.10 from $11.11 ahead of its earnings report scheduled for next Tuesday. The analyst believes that the "complexities related to DRAM scaling coupled with likely capital expenditure cuts will limit bit growth over the next few years", pressuring next year's growth rate below 20%. With deteriorating demand trends into year-end, Roy states that a more conservative approach to his DRAM average selling price assumptions is warranted.
12/11/18
GSCO
12/11/18
NO CHANGE
GSCO
Goldman Sachs lowers price targets on Micron, Western Digital after Asia tour
Goldman Sachs analyst Toshiya Hari lowered his price target on Neutral-rated Micron (MU) to $44 from $45 and on Western Digital (WDC) to $41 from $47 while also lowering his EPS view on Nvidia (NVDA) to $6.80 from $7.40 and AMD (AMD) to 50c from 52c following his tech/semi's-focused tour in Asia that included meetings with over 25 supply chain companies. The analyst claims that the findings and datapoints from the discussions were "mostly negative, especially those related to memory, HDDs, semi cap, GPUs, and smartphones". Hari sees the near-term server demand as "weak" with flattish Q1, and AI adoption being lower than expected in the supply chain. The analyst notes that industry participants saw AMD with continued market share gains as it launches its EPYC 2 products and the cadence for Intel (INTC) platform slowing as its upgrade cycle lengthens to three years from two. For Nvidia, the analyst also expects the ongoing inventory correction to spill into the April quarter.
12/10/18
KEYB
12/10/18
NO CHANGE
Target $61
KEYB
Overweight
Micron price target lowered to $61 from $73 at KeyBanc
KeyBanc analyst Weston Twigg lowered his price target for Micron to $61 from $73, while reiterating an Overweight rating on the shares. His checks indicate that demand weakness will likely persist into Q2, exacerbating a typical seasonal slowdown and driving both DRAM and NAND pricing down double-digits in Q1. Contacts indicate that for DRAM, there is only moderate oversupply, while for NAND, there is substantial oversupply, he contends.

TODAY'S FREE FLY STORIES

GILD

Gilead

$65.36

0.02 (0.03%)

07:08
10/17/19
10/17
07:08
10/17/19
07:08
Initiation
Gilead initiated  »

Gilead reinstated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 06

    Nov

MAIN

Main Street

$42.08

0.155 (0.37%)

07:08
10/17/19
10/17
07:08
10/17/19
07:08
Earnings
Main Street declares semi-annual supplemental cash dividend of 24c in December »

Main Street declared its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

POOL

Pool Corp.

$200.56

-4.63 (-2.26%)

07:08
10/17/19
10/17
07:08
10/17/19
07:08
Earnings
Pool Corp. raises FY19 EPS view $6.20-$6.40 from $6.09-$6.34 

Consensus $6.22.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 13

    Nov

PM

Philip Morris

$79.12

0.8 (1.02%)

07:08
10/17/19
10/17
07:08
10/17/19
07:08
Hot Stocks
Philip Morris revises FY19 shipment volume assumption to "down 1% - down 1.5" »

Prior guidance was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

BIIB

Biogen

$227.79

1.75 (0.77%)

07:07
10/17/19
10/17
07:07
10/17/19
07:07
Initiation
Biogen initiated  »

Biogen reinstated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

AZN

AstraZeneca

$43.80

-0.41 (-0.93%)

07:07
10/17/19
10/17
07:07
10/17/19
07:07
Hot Stocks
AstraZeneca says trastuzumab deruxtecan granted FDA Priority Review »

AstraZeneca and Daiichi…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 06

    Nov

POOL

Pool Corp.

$200.56

-4.63 (-2.26%)

07:07
10/17/19
10/17
07:07
10/17/19
07:07
Earnings
Pool Corp. reports Q3 EPS ex-items $1.84, consensus $1.78 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 13

    Nov

TXMD

TherapeuticsMD

$3.70

-0.22 (-5.61%)

07:05
10/17/19
10/17
07:05
10/17/19
07:05
Initiation
TherapeuticsMD initiated  »

TherapeuticsMD initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PM

Philip Morris

$79.12

0.8 (1.02%)

07:05
10/17/19
10/17
07:05
10/17/19
07:05
Earnings
Philip Morris lowers FY19 EPS view to 'at least $4.73' from 'at least $4.94' »

Consensus $5.21. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

NFLX

Netflix

$286.83

2.59 (0.91%)

07:05
10/17/19
10/17
07:05
10/17/19
07:05
Recommendations
Netflix analyst commentary  »

KeyBanc lowers estimates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

NBRV

Nabriva Therapeutics

$2.01

0.08 (4.15%)

07:05
10/17/19
10/17
07:05
10/17/19
07:05
Conference/Events
Nabriva Therapeutics management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

BBIO

BridgeBio

$17.92

-0.6 (-3.24%)

07:05
10/17/19
10/17
07:05
10/17/19
07:05
Hot Stocks
BridgeBio reports preclinical data on infigratinib in treating achondroplasia »

BridgeBio Pharma and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$203.28

-1.37 (-0.67%)

07:05
10/17/19
10/17
07:05
10/17/19
07:05
Initiation
Amgen initiated  »

Amgen reinstated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 06

    Nov

UCBJY

UCB

$0.00

(0.00%)

07:05
10/17/19
10/17
07:05
10/17/19
07:05
Hot Stocks
UCB says bimekizumab Phase 3 psoriasis study meets all endpoints »

UCB announced positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SASR

Sandy Spring Bancorp

$33.42

0.21 (0.63%)

07:04
10/17/19
10/17
07:04
10/17/19
07:04
Earnings
Sandy Spring Bancorp reports Q3 EPS 82c, consensus 80c »

"In the third…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

AUG

Auryn Resources

$1.28

0.09 (7.56%)

07:02
10/17/19
10/17
07:02
10/17/19
07:02
Hot Stocks
Auryn Resources stakes additional claims at Sombrero North project area »

Auryn Resources announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$45.53

0.33 (0.73%)

, WBA

Walgreens Boots Alliance

$54.66

0.15 (0.28%)

07:02
10/17/19
10/17
07:02
10/17/19
07:02
Hot Stocks
Centene, Walgreens Boots Alliance, RxAdvance announce partnership »

Centene (CNC), Walgreens…

CNC

Centene

$45.53

0.33 (0.73%)

WBA

Walgreens Boots Alliance

$54.66

0.15 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 25

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

MIST

Milestone Pharmaceuticals

$18.75

0.25 (1.35%)

07:02
10/17/19
10/17
07:02
10/17/19
07:02
Conference/Events
Milestone Pharmaceuticals management to meet with Piper Jaffray »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

PM

Philip Morris

$79.12

0.8 (1.02%)

07:02
10/17/19
10/17
07:02
10/17/19
07:02
Earnings
Philip Morris reports Q3 adjusted EPS $1.43, consensus $1.36 »

Reports Q3 net revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

MDGL

Madrigal Pharmaceuticals

$86.78

-0.49 (-0.56%)

07:00
10/17/19
10/17
07:00
10/17/19
07:00
Conference/Events
Madrigal Pharmaceuticals management to meet with Oppenheimer »

Luncheon Meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

ALXN

Alexion

$99.41

-5.435 (-5.18%)

06:58
10/17/19
10/17
06:58
10/17/19
06:58
Initiation
Alexion initiated  »

Alexion reinstated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 23

    Oct

PPG

PPG

$118.89

0.665 (0.56%)

06:58
10/17/19
10/17
06:58
10/17/19
06:58
Hot Stocks
PPG CEO says 'we made excellent progress executing on our key initiatives' »

"We delivered strong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

MNST

Monster Beverage

$56.54

0.27 (0.48%)

06:57
10/17/19
10/17
06:57
10/17/19
06:57
Downgrade
Monster Beverage rating change  »

Monster Beverage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FULC

Fulcrum Therapeutics

$4.71

-0.15 (-3.09%)

06:57
10/17/19
10/17
06:57
10/17/19
06:57
Conference/Events
Fulcrum Therapeutics management to meet with SVB Leerink »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

TSN

Tyson Foods

$81.87

-1.85 (-2.21%)

06:57
10/17/19
10/17
06:57
10/17/19
06:57
Hot Stocks
Tyson Fresh Meats to prohibit ractopamine use »

In an effort to meet…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.